Logo image of CHSCP

CHS INC - CHSINC 8 PERP (CHSCP) Stock Fundamental Analysis

USA - NASDAQ:CHSCP - US12542R2094

29.6 USD
-0.21 (-0.7%)
Last: 9/22/2025, 4:10:08 PM
Fundamental Rating

3

Taking everything into account, CHSCP scores 3 out of 10 in our fundamental rating. CHSCP was compared to 89 industry peers in the Food Products industry. CHSCP has a medium profitability rating, but doesn't score so well on its financial health evaluation. CHSCP has a expensive valuation and it also scores bad on growth. Finally CHSCP also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year CHSCP had a positive cash flow from operations.
CHSCP had positive earnings in each of the past 5 years.
In the past 5 years CHSCP always reported a positive cash flow from operatings.
CHSCP Yearly Net Income VS EBIT VS OCF VS FCFCHSCP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

1.2 Ratios

CHSCP has a Return On Assets of 2.61%. This is comparable to the rest of the industry: CHSCP outperforms 52.81% of its industry peers.
CHSCP's Return On Equity of 4.76% is in line compared to the rest of the industry. CHSCP outperforms 48.31% of its industry peers.
Looking at the Return On Invested Capital, with a value of 0.05%, CHSCP is doing worse than 64.04% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CHSCP is significantly below the industry average of 27.85%.
The 3 year average ROIC (6.11%) for CHSCP is well above the current ROIC(0.05%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 2.61%
ROE 4.76%
ROIC 0.05%
ROA(3y)8.28%
ROA(5y)6.12%
ROE(3y)15.4%
ROE(5y)11.43%
ROIC(3y)6.11%
ROIC(5y)4.27%
CHSCP Yearly ROA, ROE, ROICCHSCP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

With a Profit Margin value of 1.42%, CHSCP perfoms like the industry average, outperforming 44.94% of the companies in the same industry.
CHSCP's Profit Margin has improved in the last couple of years.
CHSCP's Operating Margin of 0.02% is on the low side compared to the rest of the industry. CHSCP is outperformed by 64.04% of its industry peers.
CHSCP's Operating Margin has declined in the last couple of years.
The Gross Margin of CHSCP (2.99%) is worse than 91.01% of its industry peers.
In the last couple of years the Gross Margin of CHSCP has remained more or less at the same level.
Industry RankSector Rank
OM 0.02%
PM (TTM) 1.42%
GM 2.99%
OM growth 3Y40.55%
OM growth 5Y-6.01%
PM growth 3Y24.89%
PM growth 5Y1.53%
GM growth 3Y21.71%
GM growth 5Y0.55%
CHSCP Yearly Profit, Operating, Gross MarginsCHSCP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1 2 3 4 5

3

2. Health

2.1 Basic Checks

CHSCP has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
CHSCP has a worse debt/assets ratio than last year.
CHSCP Yearly Shares OutstandingCHSCP Yearly Shares OutstandingYearly Shares Outstanding 2018 2M 4M 6M 8M 10M
CHSCP Yearly Total Debt VS Total AssetsCHSCP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

CHSCP has an Altman-Z score of 2.23. This is not the best score and indicates that CHSCP is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.23, CHSCP perfoms like the industry average, outperforming 55.06% of the companies in the same industry.
A Debt/Equity ratio of 0.34 indicates that CHSCP is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.34, CHSCP is in line with its industry, outperforming 58.43% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF N/A
Altman-Z 2.23
ROIC/WACC0.01
WACC4.93%
CHSCP Yearly LT Debt VS Equity VS FCFCHSCP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

2.3 Liquidity

CHSCP has a Current Ratio of 1.40. This is a normal value and indicates that CHSCP is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of CHSCP (1.40) is comparable to the rest of the industry.
A Quick Ratio of 0.86 indicates that CHSCP may have some problems paying its short term obligations.
CHSCP has a Quick ratio (0.86) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.4
Quick Ratio 0.86
CHSCP Yearly Current Assets VS Current LiabilitesCHSCP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

1

3. Growth

3.1 Past

Looking at the last year, CHSCP shows a decrease in Revenue. The Revenue has decreased by -8.96% in the last year.
CHSCP shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.24% yearly.
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-8.96%
Revenue growth 3Y0.7%
Revenue growth 5Y4.24%
Sales Q2Q%1.63%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CHSCP Yearly Revenue VS EstimatesCHSCP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

1

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
CHSCP Price Earnings VS Forward Price EarningsCHSCP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

CHSCP's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CHSCP is cheaper than 89.89% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.85
CHSCP Per share dataCHSCP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 500 1K 1.5K 2K 2.5K

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

8

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 7.27%, CHSCP is a good candidate for dividend investing.
CHSCP's Dividend Yield is rather good when compared to the industry average which is at 5.12. CHSCP pays more dividend than 92.13% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.38, CHSCP pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.27%

5.2 History

CHSCP has been paying a dividend for at least 10 years, so it has a reliable track record.
CHSCP has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years21
CHSCP Yearly Dividends per shareCHSCP Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

CHSCP pays out 32.94% of its income as dividend. This is a sustainable payout ratio.
DP32.94%
EPS Next 2YN/A
EPS Next 3YN/A
CHSCP Yearly Income VS Free CF VS DividendCHSCP Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B
CHSCP Dividend Payout.CHSCP Dividend Payout, showing the Payout Ratio.CHSCP Dividend Payout.PayoutRetained Earnings

CHS INC - CHSINC 8 PERP

NASDAQ:CHSCP (9/22/2025, 4:10:08 PM)

29.6

-0.21 (-0.7%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)07-09 2025-07-09
Earnings (Next)11-04 2025-11-04
Inst Owners11.3%
Inst Owner Change-21.43%
Ins Owners0.03%
Ins Owner Change0%
Market Cap363.19M
Analysts0
Price TargetN/A
Short Float %0.31%
Short Ratio3.66
Dividend
Industry RankSector Rank
Dividend Yield 7.27%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP32.94%
Div Incr Years0
Div Non Decr Years21
Ex-Date09-16 2025-09-16 (0.5)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF N/A
P/OCF 0.76
P/B 0.03
P/tB 0.03
EV/EBITDA 3.85
EPS(TTM)N/A
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-26.32
FCFYN/A
OCF(TTM)38.96
OCFY131.61%
SpS2936.43
BVpS878.97
TBVpS878.97
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.61%
ROE 4.76%
ROCE 0.07%
ROIC 0.05%
ROICexc 0.05%
ROICexgc 0.05%
OM 0.02%
PM (TTM) 1.42%
GM 2.99%
FCFM N/A
ROA(3y)8.28%
ROA(5y)6.12%
ROE(3y)15.4%
ROE(5y)11.43%
ROIC(3y)6.11%
ROIC(5y)4.27%
ROICexc(3y)6.66%
ROICexc(5y)4.61%
ROICexgc(3y)6.79%
ROICexgc(5y)4.69%
ROCE(3y)8.06%
ROCE(5y)5.71%
ROICexcg growth 3Y38.36%
ROICexcg growth 5Y-3.28%
ROICexc growth 3Y37.82%
ROICexc growth 5Y-3.23%
OM growth 3Y40.55%
OM growth 5Y-6.01%
PM growth 3Y24.89%
PM growth 5Y1.53%
GM growth 3Y21.71%
GM growth 5Y0.55%
F-Score3
Asset Turnover1.83
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF N/A
Debt/EBITDA 5.94
Cap/Depr 131.31%
Cap/Sales 2.22%
Interest Coverage 250
Cash Conversion 77.22%
Profit Quality N/A
Current Ratio 1.4
Quick Ratio 0.86
Altman-Z 2.23
F-Score3
WACC4.93%
ROIC/WACC0.01
Cap/Depr(3y)104.21%
Cap/Depr(5y)89.6%
Cap/Sales(3y)1.35%
Cap/Sales(5y)1.27%
Profit Quality(3y)93.36%
Profit Quality(5y)103.6%
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-8.96%
Revenue growth 3Y0.7%
Revenue growth 5Y4.24%
Sales Q2Q%1.63%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-98.83%
EBIT growth 3Y41.53%
EBIT growth 5Y-2.03%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-109.49%
FCF growth 3Y1.79%
FCF growth 5Y-7.81%
OCF growth 1Y-87.82%
OCF growth 3Y18.88%
OCF growth 5Y2.23%